FICG PARTNERS WITH MALAYSIA-LISTED CAPE EMS TO ACCELERATE AI AND OPTICAL MANUFACTURING EXPANSION
PRO3C plans to expand from eight to 18 SMT lines by the end of 2027, strengthening FICG's manufacturing capabilities and regional supply chain integration TAIPEI, Oct. 20, 2026 /PRNewswire/ -- Taiwan-listed FIC Global Inc. (FICG, TWSE: 3701)...
LG ELECTRONICS ADVANCES COOPERATIVE SAFETY VISION AT 2026 ITS WORLD CONGRESS
LG Presents Its Euro NCAP-Aligned Integrated V2X-V2N Safety Platform and Joins Global Industry Leaders in Pursuing a Zero-Accident Society News Summary LG Electronics envisions a new era of cooperative safety where vehicles, people, infrastructure...
Global Tipping Points Conference 2026 Concludes in Malaysia with Kuala Lumpur Declaration and New Roadmap for Asia
KUALA LUMPUR, Malaysia, Oct. 19, 2026 /PRNewswire/ -- The Global Tipping Points Conference 2026 (GTP 2026) was recently held at Sunway University, marking the first time the landmark global gathering was hosted in Asia. Centred on the theme "From...
Colossal to Repatriate Rare Moa Egg to Aotearoa (New Zealand)
Colossal secured one of the world's few surviving moa eggs and will entrust it to New Zealand-based moa de-extinction program partners, to ensure the egg returns to its rightful land and people. CHRISTCHURCH, New Zealand and DALLAS, Oct. 20, 2026...
Distinguished clinician-scientist Professor Marcus Ong is first Singaporean emergency medicine physician elected to National Academy of Medicine, USA
SINGAPORE, Oct. 20, 2026 /PRNewswire/ -- Professor Marcus Ong Eng Hock, Senior Consultant, Department of Emergency Medicine, Singapore General Hospital (SGH), has become the first Emergency Medicine specialist from Singapore to be elected to the...
Ascletis Announces Positive Preclinical Data for the Most Comprehensive Once-Weekly Oral Peptide Pipeline for the Treatment of Obesity
- Ascletis' industry-leading once-weekly oral peptide pipeline covers all four validated targets, with multiple first - in-class fixed - dose combinations. - ASC36o, a once-weekly oral amylin receptor peptide agonist, is the most advanced drug...
WuXi AppTec Receives Frost & Sullivan's Global Company of the Year Recognition in CRDMO for Tenth Consecutive Year
SHANGHAI, Oct. 20, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has received Frost & Sullivan's 2026 Global Company of the Year Recognition in the CRDMO...
Frost & Sullivan awards WuXi AppTec with 2026 Global Company of the Year Recognition for CRDMO Leadership
Integrated capabilities, global capacity, and customer-centric innovation strengthen WuXi AppTec's position in the evolving contract research, development, and manufacturing (CRDMO) landscape. SAN ANTONIO, Oct. 20, 2026 /PRNewswire/ -- Frost &...